SlideShare a Scribd company logo
TINA THANKACHAN
 COPD is also known as chronic obstructive
  lung disease (COLD), chronic obstructive
  airway disease (COAD), chronic airflow
  limitation (CAL) and chronic obstructive
  respiratory disease (CORD)
 Chronic obstructive pulmonary disease (COPD)
  refers to chronic bronchitis and emphysema, a
  pair of two commonly co-existing diseases of
  the lungs in which the airways become
  narrowed. This leads to a limitation of the
  flow of
 air to and from the lungs causing
 shortness of breath.
 In
   COPD, less air flows in and out of the
 airways because of one or more of the
 following:
 The airways and air sacs lose their
  elastic quality.
 The walls between many of the air sacs
  are destroyed.
 The walls of the airways become thick
  and inflamed.
 The airways make more mucus than
  usual, which tends to clog them.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
 It is the 4th leading cause of mortality and
  12th leading cause of disability in the
  united states.
 In 2020 COPD is the 3rd leading cause of
  death.
 1)Smoking
 2) Occupational exposures- exposure to
  workplace dusts found in coal mining, gold
  mining, and the cotton textile industry and
  chemicals such as cadmium, isocyanates, and
  fumes from welding have been implicated in
  the development of airflow obstruction.
 3) Air pollution
 4) sudden airway constriction in response to
  inhaled irritants,
 5) Bronchial hyperresponsiveness, is a
  characteristic of asthma.
 6)Genetics-Alpha 1-antitrypsin deficiency
 is a genetic condition that is responsible
 for about 2% of cases of COPD. In this
 condition, the body does not make enough
 of a protein, alpha 1-antitrypsin. Alpha 1-
 antitrypsin protects the lungs from
 damage caused by protease enzymes, such
 as elastase and trypsin, that can be
 released as a result of an inflammatory
 response to tobacco smoke.
NUTRITION



               INFECTIONS

            SOCIO ECONOMIC STATUS




AGING POPULATION
 Abnormal inflammatory response of the
 lungs due to toxic gases.

 Responseoccurs in the airways
 ,parenchyma & pulmonary vasculature.

 Narrowing   of the airway takes place

 Destruction
           of parenchyma leads to
 emphysema.
 Destruction of lung parenchyma leads to an imbalance
  of proteinases/antiproteinases.
(this proteinases inhibitors prevents the destructive
  process)

              Pulmonary vascularchanges
    Thickening of vessels
    Collagen deposit
    Destruction of capillary       beds.

         Mucus hypersecretion(cilia dysfunction,airflow
    limitation,corpulmonale(RVF))


               Chronic cough and sputum production
   Chronic cough
   Sputum production
   Wheezing
   Chest tightness
   Dyspnoea on exertion
   Wt.loss
   Respiratory insufficiency
   Respiratory infections
   Barrel chest- chronic hyperinflation leads
    to loss of lung elasticity.
 1) Bronchitis
 2) Emphysema
 Bronchitis :-
 Bronchitis (bron-KI-tis) is a condition in which
  the bronchial tubes become inflamed.
  acute (short term) and
 chronic (ongoing).
 Infections or lung irritants cause acute
  bronchitis.
 Chronic bronchitis is an ongoing, serious
  condition. It occurs if the lining of the
  bronchial tubes is constantly irritated and
  inflamed, causing a long-term cough with
  mucus.
 Chronic   bronchitis:
 It is defined as the presence of cough and
  sputum production for atleast 3 months.
   Irritants irrritate the airway


   Excess mucus production

   Inflammation

   Cause the mucus secreting glands and goblet cells to
    increase in number.
   Ciliary function is reduced.

   More mucus production

Bronchial walls become thickened and lumen narrows and
  mucus plug the airway

Alveoli adjacent tto the bronchioles may
  become damaged and fibrosed.

 Alter function of alveolar macrophages.

                     infection
   sore throat,
   fatigue (tiredness),
   fever, body aches,
   stuffy or runny nose,
   vomiting, and
   Diarrhea
   persistent cough
   cough may produce clear mucus
   shortness of breath
   coughing,
    wheezing, and
   chest discomfort.
   The coughing may produce large amounts
    of mucus. This type of cough often is
    called a smoker's cough.
 History - medical history
 •Whether you've recently had a cold or
  the flu
 •Whether you smoke or spend time around
  others who smoke
 •Whether you've been exposed to dust,
  fumes, vapors, or air pollution -
 Mucus  -to see whether you have a
  bacterial infection
 chest x ray,
 lung function tests,
 CBC
 ABG analysis
 MEDICAL MANAGEMENT
 SURGICAL MANAGEMENT
 NURSING MANAGEMENT
 IMPROVE   VENTILLATION
1.   BRONCHO DILATORS LIKE BETA2
     AGONISTS(ALBUTEROL),ANTICHOLINERGIC
     S(IPRATROPIUM BROMIDE-ATROVENT).
2.   METHYLXANTHINES(THEOPHYLLINE,AMIN
     OPHYLLINE)
3.   CORTICOSTEROIDS
4.   OXYGEN ADMINISTRATION
   REMOVE BRONCHIAL SECRETION
   PROMOTE EXERCISES
   CONTROL COMPLICATIONS
   IMPROVE GENERAL HEALTH
 BULLECTOMY
    BULLAE ARE ENLARGED AIRSPACES THAT
  DO NOT CONTRIBUTE TO VENTILLATION BUT
  OCCUPY SPACE IN THE THORAX,THESE AREAS
  MAY BE SURGICALLY EXCISED
 LUNG VOLUME REDUCTION SURGERY
    IT INVOLVES THE REMOVAL OF A PORTION
  OF THE DISEASED LUNG PARENCHYMA.THIS
  ALLOWS THE FUNCTIONAL TISSUE TO EXPAND.
 LUNG TRANSPLANTATION
 ASSESSMENT
 PHYSICAL EXAMINATION
 DIAGNOSIS
 INTERVENTION
 IMPAIRED GAD EXCHANGE RELATED TO
  DECREASED VENTILLATION AND MUCOUS
  PLUGS
 INEFFECTIVE AIRWAY CLEARENCE RELATED
  TO EXCESSIVE SECRETION AND INEFFECTIVE
  COUGHING
 ANXIETY RELATED TO ACUTE BREATHING
  DIFFICULTIES AND FEAR OF SUFFOCATION
 ACTIVITY INTOLERENCE RELATED TO
  INADEQUATE OXYGENATION AND DYSPNOEA
 IMBALANCED NUTRITION LESS THAN BODY REQUIREMENT
            RELATED TO REDUCED APPETITE,DECREASED ENERGY LEVEL
            AND DYSPNOEA

 DISTURBED  SLEEP PATTERN RELATED TO
  DYSPNOEA AND EXTERNAL STIMULI
 RISK FOR INFECTION RELATED TO
  INEFFECTIVE PULMONARY CLEARENCE
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
 Definition:-Emphysema   is defined as
  enlargement of the air spaces distal to
 the terminal bronchioles, with
 destruction of their walls of the alveoli.
 Pathology :
 As the alveoli are destroyed the alveolar
  surface area in contact with the
  capillaries decreases.
 Causing dead spaces (no gas exchange
  takes place)
 Leads  to hypoxia.
 In later stages:
      CO2 elimination is disturbed and
  increase in CO2 tension in arterial blood
  causing

              Respiratory acidosis
 (Decrease pulmonary blood flowis
  increased forcing the RV to maintain high
  B.P. in PA.)
 Centrilobular-Therespiratory bronchiole
 (proximal and central part of the acinus)
 is expanded. The distal acinus or alveoli
 are unchanged. Occurs more commonly in
 the upper lobes.
 Panlobular-The entire respiratory acinus,
 from respiratory bronchiole to alveoli, is
 expanded. Occurs more commonly in the
 lower lobes, especially basal segments,
 and anterior margins of the lungs.
a)   History
b)   PFT
c)   Spirometry-to find out airflow
     obstruction.
d)   ABG analysis
e)   CT scan of the lung.
f)   Screening of alpha antitrypsin deficiency
g)   X-ray radiography may aid in the
     diagnosis.
 MEDICAL MANAGEMENT
 SURGICAL MANAGEMENT
 NURSING MANAGEMENT
 IMPROVE   VENTILLATION
1.   BRONCHO DILATORS LIKE BETA2
     AGONISTS(ALBUTEROL),ANTICHOLINERGIC
     S(IPRATROPIUM BROMIDE-ATROVENT).
2.   METHYLXANTHINES(THEOPHYLLINE,AMIN
     OPHYLLINE)
3.   CORTICOSTEROIDS
4.   OXYGEN ADMINISTRATION
   REMOVE BRONCHIAL SECRETION
   PROMOTE EXERCISES
   CONTROL COMPLICATIONS
   IMPROVE GENERAL HEALTH
 BULLECTOMY
    BULLAE ARE ENLARGED AIRSPACES THAT
  DO NOT CONTRIBUTE TO VENTILLATION BUT
  OCCUPY SPACE IN THE THORAX,THESE AREAS
  MAY BE SURGICALLY EXCISED
 LUNG VOLUME REDUCTION SURGERY
    IT INVOLVES THE REMOVAL OF A PORTION
  OF THE DISEASED LUNG PARENCHYMA.THIS
  ALLOWS THE FUNCTIONAL TISSUE TO EXPAND.
 LUNG TRANSPLANTATION
 ASSESSMENT
 PHYSICAL EXAMINATION
 DIAGNOSIS
 INTERVENTION
 IMPAIRED GAD EXCHANGE RELATED TO
  DECREASED VENTILLATION AND MUCOUS
  PLUGS
 INEFFECTIVE AIRWAY CLEARENCE RELATED
  TO EXCESSIVE SECRETION AND INEFFECTIVE
  COUGHING
 ANXIETY RELATED TO ACUTE BREATHING
  DIFFICULTIES AND FEAR OF SUFFOCATION
 ACTIVITY INTOLERENCE RELATED TO
  INADEQUATE OXYGENATION AND DYSPNOEA
 DISTURBED  SLEEP PATTERN RELATED TO
  DYSPNOEA AND EXTERNAL STIMULI
 RISK FOR INFECTION RELATED TO
  INEFFECTIVE PULMONARY CLEARENCE
 IMBALANCED NUTRITION LESS THAN BODY
  REQUIREMENT RELATED TO REDUCED
  APPETITE,DECREASED ENERGY LEVEL AND
  DYSPNOEA
   Respiratory insufficiency
   Respiratory failure
   Pneumonia
   Pneumothorax
   Pulmonary artery hypertension.
 TAKEYOUR MEDICATIONS REGULARLY AS
 PRESCRIBED,IF YOU HAVE ANY DOUBT RING
 YOUR HOSPITAL.

 EXERCISEREGULARLY EVERYDAY OR ELSE
 ATLEAST 4 OUT OF 7 DAYS.
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
THANK YOU!

More Related Content

PPTX
Chronic obstructive pulmonary disorders COPD
ANILKUMAR BR
 
PPTX
COPD (Chronic obstructive Pulmonary Disease) PowerPoint Presentation -aslam
Dr.Aslam calicut
 
PPTX
Copd
education4227
 
PPTX
Copd
Yahye Abdulle
 
PPTX
Myocardial infarction
aishuanju
 
PPTX
Pneumonia
Dr.Aslam calicut
 
PPTX
Angina Pectoris
Mr. Mata Deen
 
Chronic obstructive pulmonary disorders COPD
ANILKUMAR BR
 
COPD (Chronic obstructive Pulmonary Disease) PowerPoint Presentation -aslam
Dr.Aslam calicut
 
Myocardial infarction
aishuanju
 
Pneumonia
Dr.Aslam calicut
 
Angina Pectoris
Mr. Mata Deen
 

What's hot (20)

PPT
Pathophysiology of Asthma
Ibekwe Chigozie
 
PPTX
Emphysema
Ramzee Small
 
PPTX
Chronic obstructive pulmonary disease (COPD)- Preeti sharma
Educate with smile
 
PPTX
Pathophysiology of asthma
jagadish mishra
 
PPTX
Pleural effusion
Mr. Mata Deen
 
PPT
Angina Pectoris.PPT
Manikandan T
 
PPTX
pneumonia
Hasnah Noi
 
PPTX
Lungs abscess
Mr. Mata Deen
 
PPTX
Endocarditis
Nelson Munthali
 
PPTX
COPD
Mr. Mata Deen
 
PPTX
MYOCARDIAL INFARCTION
Mr. Mata Deen
 
PPTX
Bronchial asthma
ANILKUMAR BR
 
PPTX
bronchitis - CHRONIC BRONCHITIS
Dr. Hament Sharma
 
PPT
Dyspnea
cairo1957
 
PPTX
Empyema
salman habeeb
 
PDF
Asthma
SUDESHNA BANERJEE
 
PPTX
Empyema
GAMANDEEP
 
PPTX
Pulmonary embolism ppt
resmigs
 
Pathophysiology of Asthma
Ibekwe Chigozie
 
Emphysema
Ramzee Small
 
Chronic obstructive pulmonary disease (COPD)- Preeti sharma
Educate with smile
 
Pathophysiology of asthma
jagadish mishra
 
Pleural effusion
Mr. Mata Deen
 
Angina Pectoris.PPT
Manikandan T
 
pneumonia
Hasnah Noi
 
Lungs abscess
Mr. Mata Deen
 
Endocarditis
Nelson Munthali
 
MYOCARDIAL INFARCTION
Mr. Mata Deen
 
Bronchial asthma
ANILKUMAR BR
 
bronchitis - CHRONIC BRONCHITIS
Dr. Hament Sharma
 
Dyspnea
cairo1957
 
Empyema
salman habeeb
 
Empyema
GAMANDEEP
 
Pulmonary embolism ppt
resmigs
 
Ad

Viewers also liked (20)

PPTX
Chronic obstructive pulmonary disease (copd) power point
wandatardy
 
PPT
Acute mastoiditis lecture
Rawalpindi Medical College
 
PPTX
Pathophysiology of copd
Meshal AlEnzi
 
PPTX
Pathology of COPD
Shashidhar Venkatesh Murthy
 
DOC
Pathophysiology of inguinal hernia
Gergis Rabea
 
PPT
Chronic obstructive pulmonary disease
imangalal
 
PPT
COPD (Chronic Obstructive Pulmonary Disease)
HoneymoonSwami.com
 
PPTX
Mastoiditis
Sanil Varghese
 
PPT
Digestive System Parts And Function
F Blanco
 
PPT
Dementia presentation 17 5 11
Telfordlink
 
PPTX
Physiology of the digestive system
Arti Yadav
 
PPT
The Digestive System
science_lablinks
 
PPTX
Human digestive system
Enigmatic You
 
PPTX
Proteins slides
Quanina Quan
 
PPT
Human digestive system
Simren Cena
 
PPT
Copd update 2015
Veerendra Singh
 
PPTX
Dementia
Vaishnavi S Nair
 
PPTX
Dementia PRESENTATION
Pranay Shelokar
 
PPT
Protein Powerpoint
benmoyer
 
PPTX
Classification and properties of protein
Mark Philip Besana
 
Chronic obstructive pulmonary disease (copd) power point
wandatardy
 
Acute mastoiditis lecture
Rawalpindi Medical College
 
Pathophysiology of copd
Meshal AlEnzi
 
Pathology of COPD
Shashidhar Venkatesh Murthy
 
Pathophysiology of inguinal hernia
Gergis Rabea
 
Chronic obstructive pulmonary disease
imangalal
 
COPD (Chronic Obstructive Pulmonary Disease)
HoneymoonSwami.com
 
Mastoiditis
Sanil Varghese
 
Digestive System Parts And Function
F Blanco
 
Dementia presentation 17 5 11
Telfordlink
 
Physiology of the digestive system
Arti Yadav
 
The Digestive System
science_lablinks
 
Human digestive system
Enigmatic You
 
Proteins slides
Quanina Quan
 
Human digestive system
Simren Cena
 
Copd update 2015
Veerendra Singh
 
Dementia PRESENTATION
Pranay Shelokar
 
Protein Powerpoint
benmoyer
 
Classification and properties of protein
Mark Philip Besana
 
Ad

Similar to CHRONIC OBSTRUCTIVE PULMONARY DISEASE (20)

PPTX
Copd ppt (1)
VemuJhansi
 
PPTX
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
RUTHRosilin
 
PPTX
Copd
OM VERMA
 
PPTX
Copd presentation dickson bns 3
AKANKWATSA CV DICKSON
 
PPTX
12447966345649154211787502-121127091120-phpapp02.pptx
Imtiyaz60
 
PPTX
12447966345649154211787502-121127091120-phpapp02 (1).pptx
saswati14
 
PPTX
COPD - Chronic Obstructive Pulmonary Disease |medico X| Pathology
Dr. Devkumar Sahu
 
PDF
COPD.pdf
Sani42793
 
PPTX
COPD.pptx
sapnabohra2
 
PPTX
COPD.555.pptx chronic obstructed pulmonary disease
MuhammadIqbalHaral
 
PPTX
nursing care mgmt oxygenation venti.pptx
ssuserbbb9fc
 
PPTX
COPD535.pptx
Sani191640
 
PPTX
COPD (3).pptx.. discussion slide.....
Nungshi Yengkhom
 
PPTX
COPD.pptx
GOWRI PRIYA
 
PPTX
Chronic obstructive pulmonary diseases & Nursing care.
V4Veeru25
 
PPTX
Lungs disease
Jagruti Marathe
 
PPTX
Copd
DeepiKaur2
 
PPT
upper and lower of respiratory system
faculty of nursing Tanta University
 
Copd ppt (1)
VemuJhansi
 
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
RUTHRosilin
 
Copd
OM VERMA
 
Copd presentation dickson bns 3
AKANKWATSA CV DICKSON
 
12447966345649154211787502-121127091120-phpapp02.pptx
Imtiyaz60
 
12447966345649154211787502-121127091120-phpapp02 (1).pptx
saswati14
 
COPD - Chronic Obstructive Pulmonary Disease |medico X| Pathology
Dr. Devkumar Sahu
 
COPD.pdf
Sani42793
 
COPD.pptx
sapnabohra2
 
COPD.555.pptx chronic obstructed pulmonary disease
MuhammadIqbalHaral
 
nursing care mgmt oxygenation venti.pptx
ssuserbbb9fc
 
COPD535.pptx
Sani191640
 
COPD (3).pptx.. discussion slide.....
Nungshi Yengkhom
 
COPD.pptx
GOWRI PRIYA
 
Chronic obstructive pulmonary diseases & Nursing care.
V4Veeru25
 
Lungs disease
Jagruti Marathe
 
upper and lower of respiratory system
faculty of nursing Tanta University
 

Recently uploaded (20)

PDF
Consult Best Sexologist Patna Bihar Vascular ED Problems Dr Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
 
PDF
Digital literacy note level 6 perioperative theatre technician
mercylindah47
 
PPTX
CVS INTRO.pptx therapeutics Cardiovascular disease
Dr. Sarita Sharma
 
PDF
Rheumatoid arthritis RA_and_the_liver Prof AbdelAzeim Elhefny Ain Shams Univ...
Internal medicine department, faculty of Medicine Beni-Suef University Egypt
 
PPTX
13.Anesthesia and its all types.....pptx
Bolan University of Medical and Health Sciences ,Quetta
 
PPTX
perioperative management and ERAS protocol.pptx
Fahad Ahmad
 
PPTX
Temperature Mapping in Pharmaceutical.pptx
Shehar Bano
 
PDF
Bassem Matta, CCMA
Smiling Lungs
 
PDF
coagulation disorders in anaesthesia pdf
Assist. Prof. Radhwan Hazem Alkhashab
 
PDF
Histology of Nose & paranasal sinuses - Dr Muhammad Ali Rabbani
MedicoseAcademics
 
PDF
Opening discussion for urban disease control and its challenges
Phathai Singkham
 
PPTX
Anatomy of eyelids basic anatomy covered along with abnormalities of eyelids
SummyBhatnagar1
 
PPTX
Models for screening of Local Anaesthetics.pptx
AntoRajiv1
 
PDF
Consanguineous Marriages: A Multidisciplinary Analysis of Sociocultural, Gene...
GAURAV. H .TANDON
 
PPTX
CEPHALOPELVIC DISPROPORTION (Mufeez).pptx
mufeezwanim2
 
PPTX
Nirsevimab in India - Single-Dose Monoclonal Antibody to Combat RSV .pptx
Gaurav Gupta
 
PPTX
Transfusion of Blood Components – A Guide for Nursing Faculty.pptx
AbrarKabir3
 
PPTX
CANSA Womens Health UTERINE focus Top Cancers slidedeck Aug 2025
CANSA The Cancer Association of South Africa
 
PDF
Solution of Psycho ED: Best Sexologist in Patna, Bihar India Dr. Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
 
PPTX
Optimal sites for mini-implant insertion into the infrazygomatic crest accord...
Dr Anurag JB
 
Consult Best Sexologist Patna Bihar Vascular ED Problems Dr Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
 
Digital literacy note level 6 perioperative theatre technician
mercylindah47
 
CVS INTRO.pptx therapeutics Cardiovascular disease
Dr. Sarita Sharma
 
Rheumatoid arthritis RA_and_the_liver Prof AbdelAzeim Elhefny Ain Shams Univ...
Internal medicine department, faculty of Medicine Beni-Suef University Egypt
 
13.Anesthesia and its all types.....pptx
Bolan University of Medical and Health Sciences ,Quetta
 
perioperative management and ERAS protocol.pptx
Fahad Ahmad
 
Temperature Mapping in Pharmaceutical.pptx
Shehar Bano
 
Bassem Matta, CCMA
Smiling Lungs
 
coagulation disorders in anaesthesia pdf
Assist. Prof. Radhwan Hazem Alkhashab
 
Histology of Nose & paranasal sinuses - Dr Muhammad Ali Rabbani
MedicoseAcademics
 
Opening discussion for urban disease control and its challenges
Phathai Singkham
 
Anatomy of eyelids basic anatomy covered along with abnormalities of eyelids
SummyBhatnagar1
 
Models for screening of Local Anaesthetics.pptx
AntoRajiv1
 
Consanguineous Marriages: A Multidisciplinary Analysis of Sociocultural, Gene...
GAURAV. H .TANDON
 
CEPHALOPELVIC DISPROPORTION (Mufeez).pptx
mufeezwanim2
 
Nirsevimab in India - Single-Dose Monoclonal Antibody to Combat RSV .pptx
Gaurav Gupta
 
Transfusion of Blood Components – A Guide for Nursing Faculty.pptx
AbrarKabir3
 
CANSA Womens Health UTERINE focus Top Cancers slidedeck Aug 2025
CANSA The Cancer Association of South Africa
 
Solution of Psycho ED: Best Sexologist in Patna, Bihar India Dr. Sunil Dubey
Sexologist Dr. Sunil Dubey - Dubey Clinic
 
Optimal sites for mini-implant insertion into the infrazygomatic crest accord...
Dr Anurag JB
 

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

  • 2.  COPD is also known as chronic obstructive lung disease (COLD), chronic obstructive airway disease (COAD), chronic airflow limitation (CAL) and chronic obstructive respiratory disease (CORD)  Chronic obstructive pulmonary disease (COPD) refers to chronic bronchitis and emphysema, a pair of two commonly co-existing diseases of the lungs in which the airways become narrowed. This leads to a limitation of the flow of  air to and from the lungs causing  shortness of breath.
  • 3.  In COPD, less air flows in and out of the airways because of one or more of the following:  The airways and air sacs lose their elastic quality.  The walls between many of the air sacs are destroyed.  The walls of the airways become thick and inflamed.  The airways make more mucus than usual, which tends to clog them.
  • 5.  It is the 4th leading cause of mortality and 12th leading cause of disability in the united states.  In 2020 COPD is the 3rd leading cause of death.
  • 6.  1)Smoking  2) Occupational exposures- exposure to workplace dusts found in coal mining, gold mining, and the cotton textile industry and chemicals such as cadmium, isocyanates, and fumes from welding have been implicated in the development of airflow obstruction.  3) Air pollution  4) sudden airway constriction in response to inhaled irritants,  5) Bronchial hyperresponsiveness, is a characteristic of asthma.
  • 7.  6)Genetics-Alpha 1-antitrypsin deficiency is a genetic condition that is responsible for about 2% of cases of COPD. In this condition, the body does not make enough of a protein, alpha 1-antitrypsin. Alpha 1- antitrypsin protects the lungs from damage caused by protease enzymes, such as elastase and trypsin, that can be released as a result of an inflammatory response to tobacco smoke.
  • 8. NUTRITION INFECTIONS SOCIO ECONOMIC STATUS AGING POPULATION
  • 9.  Abnormal inflammatory response of the lungs due to toxic gases.  Responseoccurs in the airways ,parenchyma & pulmonary vasculature.  Narrowing of the airway takes place  Destruction of parenchyma leads to emphysema.
  • 10.  Destruction of lung parenchyma leads to an imbalance of proteinases/antiproteinases. (this proteinases inhibitors prevents the destructive process)  Pulmonary vascularchanges  Thickening of vessels  Collagen deposit  Destruction of capillary beds.   Mucus hypersecretion(cilia dysfunction,airflow limitation,corpulmonale(RVF))   Chronic cough and sputum production
  • 11. Chronic cough  Sputum production  Wheezing  Chest tightness  Dyspnoea on exertion  Wt.loss  Respiratory insufficiency  Respiratory infections  Barrel chest- chronic hyperinflation leads to loss of lung elasticity.
  • 12.  1) Bronchitis  2) Emphysema  Bronchitis :-  Bronchitis (bron-KI-tis) is a condition in which the bronchial tubes become inflamed.
  • 13.  acute (short term) and  chronic (ongoing).  Infections or lung irritants cause acute bronchitis.  Chronic bronchitis is an ongoing, serious condition. It occurs if the lining of the bronchial tubes is constantly irritated and inflamed, causing a long-term cough with mucus.
  • 14.  Chronic bronchitis:  It is defined as the presence of cough and sputum production for atleast 3 months.
  • 15. Irritants irrritate the airway  Excess mucus production  Inflammation  Cause the mucus secreting glands and goblet cells to increase in number.  Ciliary function is reduced.  More mucus production Bronchial walls become thickened and lumen narrows and mucus plug the airway 
  • 16. Alveoli adjacent tto the bronchioles may become damaged and fibrosed. Alter function of alveolar macrophages. infection
  • 17. sore throat,  fatigue (tiredness),  fever, body aches,  stuffy or runny nose,  vomiting, and  Diarrhea  persistent cough  cough may produce clear mucus  shortness of breath
  • 18. coughing,  wheezing, and  chest discomfort.  The coughing may produce large amounts of mucus. This type of cough often is called a smoker's cough.
  • 19.  History - medical history  •Whether you've recently had a cold or the flu  •Whether you smoke or spend time around others who smoke  •Whether you've been exposed to dust, fumes, vapors, or air pollution -
  • 20.  Mucus -to see whether you have a bacterial infection  chest x ray,  lung function tests,  CBC  ABG analysis
  • 21.  MEDICAL MANAGEMENT  SURGICAL MANAGEMENT  NURSING MANAGEMENT
  • 22.  IMPROVE VENTILLATION 1. BRONCHO DILATORS LIKE BETA2 AGONISTS(ALBUTEROL),ANTICHOLINERGIC S(IPRATROPIUM BROMIDE-ATROVENT). 2. METHYLXANTHINES(THEOPHYLLINE,AMIN OPHYLLINE) 3. CORTICOSTEROIDS 4. OXYGEN ADMINISTRATION
  • 23. REMOVE BRONCHIAL SECRETION  PROMOTE EXERCISES  CONTROL COMPLICATIONS  IMPROVE GENERAL HEALTH
  • 24.  BULLECTOMY BULLAE ARE ENLARGED AIRSPACES THAT DO NOT CONTRIBUTE TO VENTILLATION BUT OCCUPY SPACE IN THE THORAX,THESE AREAS MAY BE SURGICALLY EXCISED  LUNG VOLUME REDUCTION SURGERY  IT INVOLVES THE REMOVAL OF A PORTION OF THE DISEASED LUNG PARENCHYMA.THIS ALLOWS THE FUNCTIONAL TISSUE TO EXPAND.  LUNG TRANSPLANTATION
  • 25.  ASSESSMENT  PHYSICAL EXAMINATION  DIAGNOSIS  INTERVENTION
  • 26.  IMPAIRED GAD EXCHANGE RELATED TO DECREASED VENTILLATION AND MUCOUS PLUGS  INEFFECTIVE AIRWAY CLEARENCE RELATED TO EXCESSIVE SECRETION AND INEFFECTIVE COUGHING  ANXIETY RELATED TO ACUTE BREATHING DIFFICULTIES AND FEAR OF SUFFOCATION  ACTIVITY INTOLERENCE RELATED TO INADEQUATE OXYGENATION AND DYSPNOEA
  • 27.  IMBALANCED NUTRITION LESS THAN BODY REQUIREMENT RELATED TO REDUCED APPETITE,DECREASED ENERGY LEVEL AND DYSPNOEA  DISTURBED SLEEP PATTERN RELATED TO DYSPNOEA AND EXTERNAL STIMULI  RISK FOR INFECTION RELATED TO INEFFECTIVE PULMONARY CLEARENCE
  • 29.  Definition:-Emphysema is defined as enlargement of the air spaces distal to  the terminal bronchioles, with  destruction of their walls of the alveoli.  Pathology :  As the alveoli are destroyed the alveolar surface area in contact with the capillaries decreases.  Causing dead spaces (no gas exchange takes place)
  • 30.  Leads to hypoxia.  In later stages:  CO2 elimination is disturbed and increase in CO2 tension in arterial blood causing  Respiratory acidosis  (Decrease pulmonary blood flowis increased forcing the RV to maintain high B.P. in PA.)
  • 31.  Centrilobular-Therespiratory bronchiole (proximal and central part of the acinus) is expanded. The distal acinus or alveoli are unchanged. Occurs more commonly in the upper lobes.
  • 32.  Panlobular-The entire respiratory acinus, from respiratory bronchiole to alveoli, is expanded. Occurs more commonly in the lower lobes, especially basal segments, and anterior margins of the lungs.
  • 33. a) History b) PFT c) Spirometry-to find out airflow obstruction. d) ABG analysis e) CT scan of the lung. f) Screening of alpha antitrypsin deficiency g) X-ray radiography may aid in the diagnosis.
  • 34.  MEDICAL MANAGEMENT  SURGICAL MANAGEMENT  NURSING MANAGEMENT
  • 35.  IMPROVE VENTILLATION 1. BRONCHO DILATORS LIKE BETA2 AGONISTS(ALBUTEROL),ANTICHOLINERGIC S(IPRATROPIUM BROMIDE-ATROVENT). 2. METHYLXANTHINES(THEOPHYLLINE,AMIN OPHYLLINE) 3. CORTICOSTEROIDS 4. OXYGEN ADMINISTRATION
  • 36. REMOVE BRONCHIAL SECRETION  PROMOTE EXERCISES  CONTROL COMPLICATIONS  IMPROVE GENERAL HEALTH
  • 37.  BULLECTOMY BULLAE ARE ENLARGED AIRSPACES THAT DO NOT CONTRIBUTE TO VENTILLATION BUT OCCUPY SPACE IN THE THORAX,THESE AREAS MAY BE SURGICALLY EXCISED  LUNG VOLUME REDUCTION SURGERY  IT INVOLVES THE REMOVAL OF A PORTION OF THE DISEASED LUNG PARENCHYMA.THIS ALLOWS THE FUNCTIONAL TISSUE TO EXPAND.  LUNG TRANSPLANTATION
  • 38.  ASSESSMENT  PHYSICAL EXAMINATION  DIAGNOSIS  INTERVENTION
  • 39.  IMPAIRED GAD EXCHANGE RELATED TO DECREASED VENTILLATION AND MUCOUS PLUGS  INEFFECTIVE AIRWAY CLEARENCE RELATED TO EXCESSIVE SECRETION AND INEFFECTIVE COUGHING  ANXIETY RELATED TO ACUTE BREATHING DIFFICULTIES AND FEAR OF SUFFOCATION  ACTIVITY INTOLERENCE RELATED TO INADEQUATE OXYGENATION AND DYSPNOEA
  • 40.  DISTURBED SLEEP PATTERN RELATED TO DYSPNOEA AND EXTERNAL STIMULI  RISK FOR INFECTION RELATED TO INEFFECTIVE PULMONARY CLEARENCE  IMBALANCED NUTRITION LESS THAN BODY REQUIREMENT RELATED TO REDUCED APPETITE,DECREASED ENERGY LEVEL AND DYSPNOEA
  • 41. Respiratory insufficiency  Respiratory failure  Pneumonia  Pneumothorax  Pulmonary artery hypertension.
  • 42.  TAKEYOUR MEDICATIONS REGULARLY AS PRESCRIBED,IF YOU HAVE ANY DOUBT RING YOUR HOSPITAL.  EXERCISEREGULARLY EVERYDAY OR ELSE ATLEAST 4 OUT OF 7 DAYS.